RxDoctor Payments Data

David Loran, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Harrisburg, PANPI 1215980677

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $89,475 of the $105,657 with a category attached, or 84.7%. Medtronic accounts for 95.2% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $23,530 and has fallen 80.8% since, to $4,529 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$105,657in general payments, 2019–2025

Across 251 payments — averaging $420.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$101K
  • Atricure, Inc.$3K
  • Artivion, Inc.$633
  • Silk Road Medical, Inc.$310
  • Philips North America LLC$271
  • Shockwave Medical, Inc$157
  • plus $646 from 10 others
$106,016in research payments, 2019–2025

Across 40 payments — averaging $2650.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$104K
  • Boston Scientific$2K

What the payments were for

  • Consulting fees$7501%
  • Speaking & faculty fees$89,47585%
  • Travel & lodging$5,1135%
  • Food & beverage$10,31910%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$105,657 in reported general payments places this provider in the 90th percentile of 314 thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$217,469
Medicare patients
454
Services billed
697

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Harrisburg

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →